https://www.zonebourse.com/cours/action/INNATE-PHARMA-35620/actualite/Innate-Pharma-et-AstraZeneca-annoncent-un-accord-global-pour-IPH2201-en-immuno-oncologie-20250055/?utm_source=telegram&utm_medium=social&utm_campaign=share